(Q24240050)

2

0 references

GianCarlo Avanzi

3

0 references

Romeo Brambilla

4

0 references

Fabrizio Faggiano

Cochrane Database of Systematic Reviews

5

0 references

publication date

17 February 2010

0 references

published in

0 references

cites work

Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid and alcohol-related syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Manageability and tolerability of gamma-hydroxybutyric acid in the medium term outpatient treatment of alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

[Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Attention should be given to multiplicity issues in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid intake in ethanol-preferring sP and -nonpreferring sNP rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Safety and efficacy of GABAergic medications for treating alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

A prediction model for identifying alcohol withdrawal seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

GHB: a new and novel drug of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Patients with alcohol problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Molecular pathogenesis of alcohol withdrawal seizures: the modified lipid-protein interaction mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

Gamma-hydroxybutyric acid in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: possible craving development for the drug

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

Outcome in subjects with alcohol-provoked seizures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021

Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006266.PUB2

7 January 2021